Trials / Conditions / Stage II Hepatocellular Carcinoma AJCC v8
Stage II Hepatocellular Carcinoma AJCC v8
4 registered clinical trials studyying Stage II Hepatocellular Carcinoma AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Y-90 Versus SBRT for Inoperable HCC NCT05157451 | OHSU Knight Cancer Institute | Phase 2 |
| Active Not Recruiting | Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer NCT05194293 | Academic and Community Cancer Research United | Phase 2 |
| Terminated | Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer NCT04805788 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer NCT04721132 | M.D. Anderson Cancer Center | Phase 2 |